Showing results (111-120 of 153) with videos related to

Sort By:
Pageof 16
Bone Marrow Transplantation|April 3, 2026
Mutational landscape changes of AML in patients relapsing after allogeneic hematopoietic cell transplantationKristina Maas-Bauer, Thomas Meyer, Mehtap Yücel, et al.
Leukemia Research|May 27, 2011
Induction of myeloma-specific cytotoxic T lymphocytes responses by natural killer cells stimulated-dendritic cells in patients with multiple myelomaThanh-Nhan Nguyen-Pham, Chang-Min Im, Truc-Anh Thi Nguyen, et al.
In Vivo (Athens, Greece)|October 31, 2019
Use of Droplet Digital Polymerase Chain Reaction for Detecting Minimal Residual Disease: A Prospective Multi-Institutional StudyHyunkyung Park, Dong-Yeop Shin, Inho Kim, et al.
Cellular & Molecular Immunology|August 9, 2011
Optimal culture conditions for the generation of natural killer cell-induced dendritic cells for cancer immunotherapyThanh-Nhan Nguyen-Pham, Deok-Hwan Yang, Truc-Anh Thi Nguyen, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 8, 2019
Favorable Outcomes With Tumor Burden Reduction Following Administration of Hypomethylating Agents Before Allogeneic Hematopoietic Cell Transplantation in Patients With Higher Risk Myelodysplastic SyndromeSungwoo Park, Dong Won Baek, Sang Kyun Sohn, et al.
Annals of Hematology|August 18, 2016
Report on outcomes of hypomethylating therapy for analyzing prognostic value of Revised International Prognostic Scoring System for patients with lower-risk myelodysplastic syndromesYoo Jin Lee, Sung Woo Park, In Hee Lee, et al.
Annals of Hematology|December 23, 2015
Transplant outcomes of the triple-negative NPM1/FLT3-ITD/CEBPA mutation subgroup are equivalent to those of the favourable ELN risk group, but significantly better than the intermediate-I risk group after allogeneic transplant in normal-karyotype AMLJae-Sook Ahn, Hyeoung-Joon Kim, Yeo-Kyeoung Kim, et al.
Annals of Hematology|August 4, 2018
Response to hypomethylating agents improves long-term outcomes for lower-risk patients with myelodysplastic syndrome in case-matched cohortsDong Won Baek, Yoo Jin Lee, Hyunjeong Kim, et al.
Cancers|November 13, 2021
Statins Enhance the Molecular Response in Chronic Myeloid Leukemia when Combined with Tyrosine Kinase InhibitorsHyeok-Jae Jang, Young-Min Woo, Kazuhito Naka, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 2, 2021
Favorable Long-Term Outcomes with Autologous Stem Cell Transplantation for High-Risk Multiple Myeloma Patients with a Positive Result On 18F-FDG PET/CT at BaselineHee Jeong Cho, Dong Won Baek, Ju-Hyung Kim, et al.
Pageof 16